Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Suven Life Science gets product Patent from Canada and Srilanka

      Suven Life Science gets product Patent from Canada and Srilanka

      Medical Dialogues Bureau27 Sept 2018 10:15 AM IST
      Hyderabad: Suven Life Sciences Ltd has recently announced that the grant of one product patent from Canada and one product patent from Sri Lanka...
      Despite Brexit planning, EMA fears disruption for 39 medicines

      Despite Brexit planning, EMA fears disruption for 39 medicines

      Medical Dialogues Bureau27 Sept 2018 9:15 AM IST
      LONDON: Despite actions taken by companies to prepare for Brexit, there is still a risk of serious supply disruptions for 39 medicines as a result of...
      Pharma sector: Cabinet Approval for India-Uzbekistan MoU on cooperation

      Pharma sector: Cabinet Approval for India-Uzbekistan MoU on cooperation

      Medical Dialogues Bureau27 Sept 2018 9:00 AM IST
      The MoU will explore the possibilities for the production of medicines, including active pharmaceutical ingredients (APIs) in different therapeutic...
      Asia Healthcare in talks to acquire Nova IVI Fertility

      Asia Healthcare in talks to acquire Nova IVI Fertility

      Medical Dialogues Bureau26 Sept 2018 5:55 PM IST
      New Delhi: Asia Healthcare Holdings (AHH), an operating and investment platform founded by TPG Growth, the global middle market and growth equity...
      Veneeth Purushotaman joined to Aster DM Healthcare as the Group CIO

      Veneeth Purushotaman joined to Aster DM Healthcare as the Group CIO

      Medical Dialogues Bureau26 Sept 2018 3:55 PM IST
      Purushotaman will be responsible for creating and driving the global IT strategy of the company and consolidating its technology landscape across...
      FIRST: Needle, syringe makers tell government to regulate their prices

      FIRST: Needle, syringe makers tell government to regulate their prices

      Medical Dialogues Bureau26 Sept 2018 3:41 PM IST
      New Delhi: All India Syringes and Needles Manufacturers Association (AISNMA) has written a letter to NELM on price capping of essential syringes and...
      Boston Scientific introduces LithoVue Empower-kidney stone reterival device

      Boston Scientific introduces LithoVue Empower-kidney stone reterival device

      Medical Dialogues Bureau26 Sept 2018 9:48 AM IST
      The LithoVue Empower Device was developed in direct response to a need to improve procedural bottlenecks during kidney stone removal...
      Boosting profitability: Novartis to cut 2,200 jobs in Switzerland

      Boosting profitability: Novartis to cut 2,200 jobs in Switzerland

      Medical Dialogues Bureau26 Sept 2018 9:30 AM IST
      With 450 new positions being created for the production of cell and gene therapies, Swiss positions will be cut by about 1,750 net jobs.ZURICH:...
      Gilead to launch low-cost generic versions of its hepatitis drugs

      Gilead to launch low-cost generic versions of its hepatitis drugs

      Medical Dialogues Bureau26 Sept 2018 9:00 AM IST
      Gilead said the low-cost variants of the drugs will be available at a list price of $24,000 for the most common course of therapy from January.New...
      USFDA completes inspection of Biocon drug substance unit at Bengaluru

      USFDA completes inspection of Biocon drug substance unit at Bengaluru

      Medical Dialogues Bureau25 Sept 2018 1:46 PM IST
      No ObservationsBanglore: Biotechnology major Biocon has said the inspection of its drug substance manufacturing site at Bengaluru campus by the US...
      Cipla received USFDA approval for Albendazole

      Cipla received USFDA approval for Albendazole

      Medical Dialogues Bureau25 Sept 2018 11:19 AM IST
      Albendazole is an anti-worm medication drug. It prevents newly hatched insect larvae (worms) from growing or multiplying in our body. Mumbai: Cipla...
      With new blood test, Roche dives deeper into personal cancer care

      With new blood test, Roche dives deeper into personal cancer care

      Medical Dialogues Bureau25 Sept 2018 9:42 AM IST
      Cancer is a disease of the genome and genomic profiling of every patient's tumour at the start of their treatment journey will provide transformative...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok